0001209191-23-054904.txt : 20231109 0001209191-23-054904.hdr.sgml : 20231109 20231109203253 ACCESSION NUMBER: 0001209191-23-054904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231107 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ENRIGHT PATRICK G CENTRAL INDEX KEY: 0001253886 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41855 FILM NUMBER: 231394334 MAIL ADDRESS: STREET 1: CO LONGITUDE CAPITAL PARTNERS LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tammenoms Bakker Juliet CENTRAL INDEX KEY: 0001431159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41855 FILM NUMBER: 231394335 MAIL ADDRESS: STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longitude Venture Partners IV, L.P. CENTRAL INDEX KEY: 0001787456 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41855 FILM NUMBER: 231394336 BUSINESS ADDRESS: STREET 1: 2740 SAND HILL ROAD STREET 2: 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 854-5700 MAIL ADDRESS: STREET 1: 2740 SAND HILL ROAD STREET 2: 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longitude Capital Partners IV, LLC CENTRAL INDEX KEY: 0001829169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41855 FILM NUMBER: 231394337 BUSINESS ADDRESS: STREET 1: 2740 SAND HILL ROAD STREET 2: 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-854-5700 MAIL ADDRESS: STREET 1: 2740 SAND HILL ROAD STREET 2: 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexeo Therapeutics, Inc. CENTRAL INDEX KEY: 0001907108 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 854012572 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: FLOOR 6 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (212) 547-9879 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: FLOOR 6 CITY: NEW YORK STATE: NY ZIP: 10010 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-07 0 0001907108 Lexeo Therapeutics, Inc. LXEO 0001829169 Longitude Capital Partners IV, LLC 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 94025 0 0 1 0 0001787456 Longitude Venture Partners IV, L.P. 2740 SAND HILL ROAD 2ND FLOOR MENLO PARK CA 0 0 1 0 0001431159 Tammenoms Bakker Juliet C/O LONGITUDE CAPITAL 2740 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025 0 0 1 0 0001253886 ENRIGHT PATRICK G C/O LONGITUDE CAPITAL 2740 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025 0 0 1 0 0 Common Stock 2023-11-07 4 C 0 1793429 A 1793429 I By Longitude Venture Partners IV, L.P. Common Stock 2023-11-07 4 C 0 319126 A 2112555 I By Longitude Venture Partners IV, L.P. Common Stock 2023-11-07 4 P 0 454545 11.00 A 2567100 I By Longitude Venture Partners IV, L.P. Series A convertible preferred stock 2023-11-07 4 C 0 18999999 D Common Stock 1793429 0 I By Longitude Venture Partners IV, L.P. Series B convertible preferred stock 2023-11-07 4 C 0 2906148 D Common Stock 319126 0 I By Longitude Venture Partners IV, L.P. Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date. These shares are held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date. Longitude Capital Partners IV, LLC By: /s/ Cristiana Blauth Oliveira , Authorized Signatory 2023-11-09 Longitude Venture Partners IV, L.P. By: /s/ Cristiana Blauth Oliveira , Authorized Signatory of the General Partner 2023-11-09 /s/ Cristiana Blauth Oliveira, Attorney-in-Fact for Juliet Tammenoms Bakker 2023-11-09 /s/ Cristiana Blauth Oliveira, Attorney-in-Fact for Patrick Enright 2023-11-09